The aim of this study was to evaluate the efficacy and safety of peptide-targeted radionuclide therapy (PTRT) with 177Lu-FAP-2286 in advanced lung cancer.

AIに質問

Bookmark

View Full Paper

AIに質問

Bookmark

View Full Paper

Cite This Study

Xie et al. (Sun,) studied this question.

synapsesocial.com/papers/68e6859ab6db64358760e5f5 https://doi.org/https://doi.org/10.1097/rlu.0000000000005297

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1The role of fibroblast activation protein in health and malignancy2020 · 584 citations
2PROTAC therapy as a new targeted therapy for lung cancer2022 · 83 citations
3The End of Nihilism: Systemic Therapy of Advanced Non–Small Cell Lung Cancer2016 · 29 citations
4Identification of Novel Natural Substrates of Fibroblast Activation Protein-alpha by Differential Degradomics and Proteomics2018 · 67 citations
5Managing the TME to improve the efficacy of cancer therapy2022 · 297 citations

Efficacy and Safety Evaluation of 177Lu-FAP-2286 in the Treatment of Advanced Lung Cancer | Synapse

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1The role of fibroblast activation protein in health and malignancy2020 · 584 citations
2PROTAC therapy as a new targeted therapy for lung cancer2022 · 83 citations
3The End of Nihilism: Systemic Therapy of Advanced Non–Small Cell Lung Cancer2016 · 29 citations
4Identification of Novel Natural Substrates of Fibroblast Activation Protein-alpha by Differential Degradomics and Proteomics2018 · 67 citations
5Managing the TME to improve the efficacy of cancer therapy2022 · 297 citations